Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001977548-24-000004
Filing Date
2024-02-14
Accepted
2024-02-14 13:09:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 kala_13gv3.htm SC 13G/A 78255
  Complete submission text file 0001977548-24-000004.txt   79885
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Subject) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90054 | Film No.: 24635344
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 611 WASHINGTON STREET SAN FRANCISCO CA 94111
Business Address 611 WASHINGTON STREET SAN FRANCISCO CA 94111 914-355-0570
Checkpoint Capital L.P. (Filed by) CIK: 0001977548 (see all company filings)

EIN.: 884375303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A